Cargando…
Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data
MYCN, an oncogenic transcription factor of the Myc family, is a major driver of neuroblastoma tumorigenesis. Due to the difficulty in drugging MYCN directly, revealing the molecules in MYCN regulatory networks will help to identify effective therapeutic targets for neuroblastoma therapy. Here we per...
Autores principales: | Hsu, Chia-Lang, Chang, Hsin-Yi, Chang, Jen-Yun, Hsu, Wen-Ming, Huang, Hsuan-Cheng, Juan, Hsueh-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095001/ https://www.ncbi.nlm.nih.gov/pubmed/27167114 http://dx.doi.org/10.18632/oncotarget.9202 |
Ejemplares similares
-
Aryl Hydrocarbon Receptor Downregulates MYCN Expression and Promotes Cell Differentiation of Neuroblastoma
por: Wu, Pei-Yi, et al.
Publicado: (2014) -
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018) -
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
por: Fuchs, Steffen, et al.
Publicado: (2023) -
The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2016) -
MYCN Function in Neuroblastoma Development
por: Otte, Jörg, et al.
Publicado: (2021)